Patrick Lu

Company: Siranomics
Job title: President & CEO
Seminars:
Clinical Study Readouts for Novel RNAi Cancer Therapeutics 9:00 am
Advantage of polypeptide nanoparticle delivery for siRNA cancer therapeutics STP705 local formulation for treatment of non-melanoma skin cancers STP707 systemic formulation for treatment of liver and pancreatic cancersRead more
day: Day One